Clinical Trials Logo

Critical Illness clinical trials

View clinical trials related to Critical Illness.

Filter by:

NCT ID: NCT03863470 Completed - Critical Illness Clinical Trials

Study of Therapeutic Exercise in Acute Respiratory Failure to Improve Neuromuscular Disability Trial

STAND
Start date: March 4, 2019
Phase: N/A
Study type: Interventional

This is a stepped-wedge, cluster randomized, trial evaluating the effect of an early goal-directed mobilization intervention for ICU patients with acute respiratory failure within 12 medical and surgical ICUs across 4 hospitals in the University of Pennsylvania Health System. The investigators will conduct a 54-week trial to measure the effect of the intervention on multiple patient-centered outcomes of patient physical function and cognition, in addition to ICU and hospital length of stay and duration of mechanical ventilation compared to usual care.

NCT ID: NCT03861117 Completed - Clinical trials for Critically Ill Adult Patients With Difficult Weaning

Pressure Support and Positive End Expiratory Pressure During Spontaneous Breathing Trial

SBT-ICU
Start date: May 10, 2019
Phase: N/A
Study type: Interventional

The aim of this study is to assess if a bundle associating pressure support and positive end-expiratory pressure during spontaneous breathing trial and detection by T-piece of patients with high-risk of extubation failure can reduce the time to successful extubation in critically ill patients.

NCT ID: NCT03851822 Completed - Critical Illness Clinical Trials

Prevalence and Predictors of CCI in Patients With Acute Respiratory Failure (CCI)

CCI
Start date: January 1, 2016
Phase:
Study type: Observational

Chronic Critical Illness (CCI) is a condition associated to patients surviving an acute phase of disease and respiratory failure (ARF) although remaining dependent on mechanical ventilation (MV). The prevalence and the underlying mechanisms of CCI have not been elucidated in this population.An observational prospective cohort study was undertaken at the Respiratory Intensive Care Unit (RICU) of the University Hospital of Modena (Italy) from January 2016 to January 2018. Patients mechanically ventilated with ARF in this unit were enrolled. Demographics, diagnosis, severity scores (APACHEII, SOFA, SAPSII) and clinical conditions (septic shock, infections, acute respiratory distress syndrome [ARDS]) were recorded on admission. Respiratory mechanics and inflammatory-metabolic blood parameters were recorded on admission and within the first seven days of stay. All these variables were tested as potential predictors of CCI through appropriate univariate and multivariate analysis.

NCT ID: NCT03851354 Completed - Clinical trials for Enteral Feeding Intolerance

Ultrasound Meal Accommodation Test for Enteral Feeding in the Critically Ill

UMATI
Start date: April 1, 2019
Phase: N/A
Study type: Interventional

Within the context of intensive care units (ICU), enteral nutrition (NE) is an essential tool in the management of critical patients. Gastrointestinal dysfunction causes significant difficulties in implementing enteral nutrition, and constitutes one of the main medical or non-avoidable causes to avoid enteral feeding in critically ill patients. Gastric ultrasound is a validated tool to non-invasively evaluate gastric volume and content. The purpose of this study is to evaluate the use of this test in critically ill patients for initiation and tolerance of the enteral feeding.

NCT ID: NCT03847155 Completed - Nicotine Dependence Clinical Trials

Prevention of Nicotine Abstinence in Critically Ill Patients After Major Surgery

Start date: September 23, 2015
Phase: N/A
Study type: Interventional

The primary objective of this study is to determine whether the application of transdermal nicotine patches in critically ill patients after major surgery with nicotine abstinence condition is associated with a lower incidence of delirium.

NCT ID: NCT03835091 Completed - Brainstem Response Clinical Trials

Use of BRASS in Sedated Critically-ill Patients as a Predictable Mortality Factor

BRASS-ICU
Start date: February 7, 2019
Phase:
Study type: Observational

Sedation is used for 30 to 70 % of all intensive care unit (ICU) patients. Deep sedation can be used for lot of disease like acute respiratory distress syndrome, septic shock. Deep sedation was defined by RASS (Richmond Assessment Sedation Scale) below -3. Deep sedation can be associated with increased mortality, length stay, duration of mechanical ventilation, acute brain dysfunction. The french exploration neurologic group in ICU developed a score used Brainstem response patterns in patient deeply sedated by midazolam and showed that a high BRASS score is associated with high mortality at day 28. The investigators think that BRASS score isn't associated with the medication used for sedation. In this study the investigators included all patients sedated independently of medication used for sedation, we also excluded patient with neurologic disorder. The main objective is to shown that high BRASS score at admission of patient without neurologic disorder sedated is predictive of 28-day mortality.

NCT ID: NCT03828630 Completed - Clinical trials for Acute Respiratory Distress Syndrome

Lung Ultrasound to Detect Pulmonary Complications in Critically Ill Parturients

LUSIP
Start date: July 8, 2018
Phase:
Study type: Observational

This study aims at describing the frequency, timing and type of pulmonary complications detected with lung ultrasound in critically-ill parturients in admitted to a high-dependency unit in Freetown, Sierra Leone.

NCT ID: NCT03819959 Completed - Critical Illness Clinical Trials

Metabolomics Study on Intensive Care Acquired Muscle Weakness in Polytrauma

MIRACLE II
Start date: March 24, 2019
Phase:
Study type: Observational

In this mono-center pilot trial, polytrauma patients admitted to intensive care will be included. Investigators are going to take blood and muscle samples at respecified time points to do metabolic, histological and molecular testing. Aim of the study is to investigate (1) changes of the blood metabolome in patients with ICUAW (intensive care unit acquired weakness) and (2) identify metabolic components who are responsible for ICUAW or can be used as marker for ICUAW.

NCT ID: NCT03798600 Completed - Critical Illness Clinical Trials

Pharmacokinetics/Pharmacodynamics (PK/PD) of Caspofungin in Intensive Care Unit (ICU) Patients. An Open Observational Study for Antifungal Treatment's Optimization

Start date: January 1, 2016
Phase:
Study type: Observational

PK of Caspofungin in ICU septic patients might be changed as compared to healthy volunteers due to sepsis-related pathophysiology. Sub-optimal plasma and tissue concentrations might be achieved in these patients when drugs are administered at the same dosage/regimen suggested for healthy volunteers.

NCT ID: NCT03796338 Completed - Critical Illness Clinical Trials

Sleep Quantity and Quality in the ICU: a Prospective Observational Stud

Start date: February 1, 2018
Phase:
Study type: Observational

Several evidences in the literature suggest sleep interruption in critical care patients. Nowadays, the amount and the quality of sleep phases during the length of stay in the intensive care unit are largely unknown. In this study, the amount of time spent by the patients in N1, N2 N3 and REM phases during sleep is quantified.